Conduit Pharmaceuticals Stock Analysis

Conduit Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 23.0. Conduit Pharmaceuticals had not issued any dividends in recent years. The entity had 1:100 split on the 27th of January 2025. For more info on Conduit Pharmaceuticals please contact David Tapolczay at 760 471 8536 or go to https://www.conduitpharma.com.

Conduit Pharmaceuticals Investment Alerts

Conduit Pharmaceuticals Upcoming and Recent Events

Conduit Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 5.44 M.

Conduit Profitablity

Management Efficiency

Conduit Pharmaceuticals has Return on Asset of (1.088) % which means that on every $100 spent on assets, it lost $1.088. This is way below average. Conduit Pharmaceuticals' management efficiency ratios could be used to measure how well Conduit Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Conduit Pharmaceuticals' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.06 in 2025, whereas Return On Capital Employed is likely to drop 0.1 in 2025. Total Current Liabilities is likely to gain to about 653.8 M in 2025. Liabilities And Stockholders Equity is likely to gain to about 3.4 B in 2025

Technical Drivers

As of the 25th of March, Conduit Pharmaceuticals shows the Mean Deviation of 9.93, risk adjusted performance of (0.1), and Standard Deviation of 16.73. Conduit Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Conduit Pharmaceuticals Price Movement Analysis

Conduit Pharmaceuticals Insider Trading Activities

Conduit Pharmaceuticals Predictive Daily Indicators

Conduit Pharmaceuticals Forecast Models

Conduit Pharmaceuticals' time-series forecasting models are one of many Conduit Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Conduit Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Conduit Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Conduit shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Conduit Pharmaceuticals. By using and applying Conduit Stock analysis, traders can create a robust methodology for identifying Conduit entry and exit points for their positions.

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.